Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Escudier

Showing results (31-40 of 189) with videos related to

Pageof 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Exosomes for cancer immunotherapyF Andre, B Escudier, E Angevin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
How to select amongst available options for the treatment of advanced RCC?B Escudier, L Albiges, C Massard, et al.
Bulletin Du Cancer|July 1, 1993
[Cancer immunotherapy: immunologic bases, reality and hopes]P Y Dietrich, F Farace, A Caignard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2015
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinomaH Izzedine, L Derosa, G Le Teuff, et al.
British Journal of Cancer|November 19, 2009
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinibG Mickisch, M Gore, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinomaS Antoun, V E Baracos, L Birdsell, et al.
Infection Control and Hospital Epidemiology|January 1, 1990
Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unitM Guiguet, C Rekacewicz, B Leclercq, et al.
Cahiers D'Anesthesiologie|January 1, 1985
[Pseudoparalysis induced by cancer chemotherapy (cis-platinum)]B Leclercq, B Escudier, F Tandonnet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1984
[Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine]A Kulas, B Escudier, N Hannachi, et al.
International Journal of Cancer|June 15, 1994
Metastatic renal-cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon gamma: immunological monitoringF Farace, M Pallardy, E Angevin, et al.
Pageof 19

Showing results (31-40 of 189) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Exosomes for cancer immunotherapyF Andre, B Escudier, E Angevin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
How to select amongst available options for the treatment of advanced RCC?B Escudier, L Albiges, C Massard, et al.
Bulletin Du Cancer|July 1, 1993
[Cancer immunotherapy: immunologic bases, reality and hopes]P Y Dietrich, F Farace, A Caignard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2015
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinomaH Izzedine, L Derosa, G Le Teuff, et al.
British Journal of Cancer|November 19, 2009
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinibG Mickisch, M Gore, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinomaS Antoun, V E Baracos, L Birdsell, et al.
Infection Control and Hospital Epidemiology|January 1, 1990
Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unitM Guiguet, C Rekacewicz, B Leclercq, et al.
Cahiers D'Anesthesiologie|January 1, 1985
[Pseudoparalysis induced by cancer chemotherapy (cis-platinum)]B Leclercq, B Escudier, F Tandonnet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1984
[Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine]A Kulas, B Escudier, N Hannachi, et al.
International Journal of Cancer|June 15, 1994
Metastatic renal-cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon gamma: immunological monitoringF Farace, M Pallardy, E Angevin, et al.
Pageof 19